Paper41366580
Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics.
Iwaki Y and 3 others. AAPS J, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics. Papers, record 41366580. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41366580
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dutasteride | Major topic |
| Finasteride | Major topic |
| 5-alpha Reductase Inhibitors | Major topic |
| Models, Biological | Major topic |
| Humans | |
| Male | |
| Nonlinear Dynamics | |
| Tissue Distribution |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36914276 | Predicting In Vivo Target Occupancy (TO) Profiles via Physiologically Based Pharmacokinetic-TO Modeling of Warfarin Pharmacokinetics in Blood: Importance of Low Dose Data and Prediction of Stereoselective Target Interactions. | Drug Metab Dispos | 2023 | https://conductscience.org/library/papers/36914276 | PubMed |
| 2 | 29472637 | Impact of target interactions on small-molecule drug disposition: an overlooked area. | Nat Rev Drug Discov | 2018 | https://conductscience.org/library/papers/29472637 | PubMed |
| 3 | 37853850 | Cluster Gauss-Newton method for a quick approximation of profile likelihood: With application to physiologically-based pharmacokinetic models. | CPT Pharmacometrics Syst Pharmacol | 2024 | https://conductscience.org/library/papers/37853850 | PubMed |
| 4 | 9871428 | A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride. | Clin Pharmacol Ther | 1998 | https://conductscience.org/library/papers/9871428 | PubMed |
| 5 | 39435882 | Elucidation of DPP-4 involvement in systemic distribution and renal reabsorption of linagliptin by PBPK modeling with a cluster Gauss-Newton method. | Clin Transl Sci | 2024 | https://conductscience.org/library/papers/39435882 | PubMed |
| 6 | 2538808 | Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humans. | Prostate | 1989 | https://conductscience.org/library/papers/2538808 | PubMed |
| 7 | 35945914 | Cluster Gauss-Newton method analyses of PBPK model parameter combinations of coproporphyrin-I based on OATP1B-mediated rifampicin interaction studies. | CPT Pharmacometrics Syst Pharmacol | 2022 | https://conductscience.org/library/papers/35945914 | PubMed |
| 8 | 16639716 | Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. | J Pharm Sci | 2006 | https://conductscience.org/library/papers/16639716 | PubMed |
| 9 | 29928850 | Importance of target-mediated drug disposition for small molecules. | Drug Discov Today | 2018 | https://conductscience.org/library/papers/29928850 | PubMed |
| 10 | 32901140 | Phase 0/microdosing approaches: time for mainstream application in drug development? | Nat Rev Drug Discov | 2020 | https://conductscience.org/library/papers/32901140 | PubMed |
| 11 | 28472278 | Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels. | Endocr Rev | 2017 | https://conductscience.org/library/papers/28472278 | PubMed |
| 12 | 15858854 | Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. | J Pharm Sci | 2005 | https://conductscience.org/library/papers/15858854 | PubMed |
| 13 | 10495374 | The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. | J Am Acad Dermatol | 1999 | https://conductscience.org/library/papers/10495374 | PubMed |
| 14 | 8389191 | Finasteride: a slow-binding 5 alpha-reductase inhibitor. | Biochemistry | 1993 | https://conductscience.org/library/papers/8389191 | PubMed |
| 15 | 7577933 | Mechanism of time-dependent inhibition of 5 alpha-reductases by delta 1-4-azasteroids: toward perfection of rates of time-dependent inhibition by using ligand-binding energies. | Biochemistry | 1995 | https://conductscience.org/library/papers/7577933 | PubMed |
| 16 | 8654202 | Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride. | Drug Metab Dispos | 1995 | https://conductscience.org/library/papers/8654202 | PubMed |
| 17 | 10073740 | The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination. | Br J Clin Pharmacol | 1999 | https://conductscience.org/library/papers/10073740 | PubMed |
| 18 | 8378254 | Physiological parameters in laboratory animals and humans. | Pharm Res | 1993 | https://conductscience.org/library/papers/8378254 | PubMed |
| 19 | 33558262 | Revisiting Nonlinear Bosentan Pharmacokinetics by Physiologically Based Pharmacokinetic Modeling: Target Binding, Albeit Not a Major Contributor to Nonlinearity, Can Offer Prediction of Target Occupancy. | Drug Metab Dispos | 2021 | https://conductscience.org/library/papers/33558262 | PubMed |
| 20 | 15126539 | Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. | J Clin Endocrinol Metab | 2004 | https://conductscience.org/library/papers/15126539 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41366580
GET https://conductscience.org/api/papers/v1/41366580/references?page=2